These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30249155)

  • 1. Polymyalgia rheumatica due to pembrolizumab therapy.
    Iskandar A; Hwang A; Dasanu CA
    J Oncol Pharm Pract; 2019 Jul; 25(5):1282-1284. PubMed ID: 30249155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab.
    Perrotta FM; Scriffignano S; Fatica M; Specchia M; Lubrano E
    Reumatismo; 2020 Nov; 72(3):178-181. PubMed ID: 33213131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pembrolizumab-induced polymyalgia rheumatica in two patients with metastatic melanoma.
    Garel B; Kramkimel N; Trouvin AP; Frantz C; Dupin N
    Joint Bone Spine; 2017 Mar; 84(2):233-234. PubMed ID: 27133763
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of a Low-dose Corticosteroid in a Patient with Polymyalgia Rheumatica Associated with Nivolumab Treatment].
    Imai Y; Tanaka M; Fujii R; Uchitani K; Okazaki K
    Yakugaku Zasshi; 2019; 139(3):491-495. PubMed ID: 30828027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Belkhir R; Burel SL; Dunogeant L; Marabelle A; Hollebecque A; Besse B; Leary A; Voisin AL; Pontoizeau C; Coutte L; Pertuiset E; Mouterde G; Fain O; Lambotte O; Mariette X
    Ann Rheum Dis; 2017 Oct; 76(10):1747-1750. PubMed ID: 28600350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia rheumatica after pembrolizumab treatment.
    Ramirez-Poza S; Pardo-Cabello AJ; Salvatierra J
    Med Clin (Barc); 2023 Sep; 161(6):270-271. PubMed ID: 37271671
    [No Abstract]   [Full Text] [Related]  

  • 7. Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.
    Hwang A; Iskandar A; Dasanu CA
    J Oncol Pharm Pract; 2019 Sep; 25(6):1520-1522. PubMed ID: 30086678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab.
    Kethireddy N; Thomas S; Bindal P; Shukla P; Hegde U
    J Oncol Pharm Pract; 2021 Jan; 27(1):207-211. PubMed ID: 32390537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia rheumatica in a melanoma patient 11 months after completion of immunotherapy with nivolumab.
    Lobo Y; Good P; Murphy F
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1244. PubMed ID: 32671986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab-Induced Polymyalgia Rheumatica in a Patient with Lung Adenocarcinoma.
    Kita T; Araya T; Sakai T; Uchida Y; Matsuoka H; Kasahara K
    Am J Med Sci; 2021 Sep; 362(3):321-323. PubMed ID: 33905737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma.
    Sepúlveda M; Martinez-Hernandez E; Gaba L; Victoria I; Sola-Valls N; Falgàs N; Casanova-Molla J; Graus F
    Muscle Nerve; 2017 Dec; 56(6):E162-E167. PubMed ID: 28439919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.
    Acero Brand FZ; Suter N; Adam JP; Faulques B; Maietta A; Soulières D; Blais N
    J Immunother Cancer; 2018 Mar; 6(1):22. PubMed ID: 29548299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs and new toxicities: pembrolizumab-induced myocarditis.
    Inayat F; Masab M; Gupta S; Ullah W
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29367376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
    Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
    J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.
    Yip RHL; Lee LH; Schaeffer DF; Horst BA; Yang HM
    Melanoma Res; 2018 Dec; 28(6):645-647. PubMed ID: 30256271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica.
    Robilliard B; Arnaud E; Gastaud L; Broner J
    Eur J Cancer; 2018 Nov; 103():281-283. PubMed ID: 30286977
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient: A case report.
    Li S; Zhang Y; Sun Z; Hu J; Fang C
    Medicine (Baltimore); 2018 Nov; 97(45):e12907. PubMed ID: 30407284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases.
    Blakeway EA; Elshimy N; Muinonen-Martin A; Marples M; Mathew B; Mitra A
    Melanoma Res; 2019 Jun; 29(3):338-341. PubMed ID: 30762712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.